People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PIC Therapeutics, Inc. | — | Biotechnology | Series A | $19.6M | $78.5M | 2022 |
Dr. Katherine S. Bowdish at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Katherine S. Bowdish on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerry E. Brunk | 1 | 1 |
| Tal E. Zaks, MD, PhD | 1 | 1 |
| Belinda E. Termeer | 1 | 1 |
| Dr. Alan E. Walts | 1 | 1 |
| Dr. Gerhard E. Wagner | 1 | 1 |
| Dr. Richard E. Peters | 1 | 1 |
| Sun Altbach | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.